MongoDB, Inc. (NASDAQ: MDB) Stock Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/17/2024 | 21.94% | Needham | → $495 | Reiterates | Buy → Buy |
| 01/04/2024 | 1% | UBS | $475 → $410 | Downgrades | Buy → Neutral |
| 12/06/2023 | 3.46% | Mizuho | $330 → $420 | Maintains | Neutral |
| 12/06/2023 | 17.01% | RBC Capital | $445 → $475 | Maintains | Outperform |
| 12/06/2023 | 17.75% | Barclays | $470 → $478 | Maintains | Overweight |
| 12/06/2023 | 21.94% | Needham | $445 → $495 | Maintains | Buy |
| 12/06/2023 | 23.17% | Piper Sandler | $425 → $500 | Maintains | Overweight |
| 12/04/2023 | 10.85% | Stifel | → $450 | Reiterates | Buy → Buy |
| 11/16/2023 | 23.17% | Wells Fargo | → $500 | Initiates Coverage On | → Overweight |
| 11/13/2023 | 5.92% | Truist Securities | → $430 | Reiterates | Buy → Buy |
| 11/08/2023 | 5.19% | Capital One | → $427 | Upgrades | Equal-Weight → Overweight |
| 10/23/2023 | 8.39% | Keybanc | $495 → $440 | Maintains | Overweight |
| 10/12/2023 | 10.85% | B of A Securities | → $450 | Initiates Coverage On | → Buy |
| 10/10/2023 | -17.48% | Scotiabank | → $335 | Initiates Coverage On | → Sector Perform |
| 10/06/2023 | 21.94% | Tigress Financial | $490 → $495 | Reiterates | Buy → Buy |
| 09/05/2023 | 10.85% | Canaccord Genuity | $410 → $450 | Maintains | Buy |
| 09/05/2023 | 19.23% | Argus Research | $435 → $484 | Maintains | Buy |
| 09/01/2023 | 14.55% | UBS | $425 → $465 | Maintains | Buy |
| 09/01/2023 | 5.92% | Truist Securities | $420 → $430 | Maintains | Buy |
| 09/01/2023 | 18.24% | Morgan Stanley | $440 → $480 | Maintains | Overweight |
| 09/01/2023 | 9.62% | RBC Capital | → $445 | Reiterates | Outperform → Outperform |
| 09/01/2023 | 10.85% | Barclays | $421 → $450 | Maintains | Overweight |
| 09/01/2023 | -38.42% | Guggenheim | $220 → $250 | Maintains | Sell |
| 09/01/2023 | 10.85% | Stifel | $420 → $450 | Maintains | Buy |
| 09/01/2023 | 18.24% | Oppenheimer | $430 → $480 | Maintains | Outperform |
| 09/01/2023 | 8.39% | JMP Securities | $425 → $440 | Maintains | Market Outperform |
| 09/01/2023 | 9.62% | Needham | $430 → $445 | Maintains | Buy |
| 09/01/2023 | 4.69% | Piper Sandler | $400 → $425 | Maintains | Overweight |
| 08/28/2023 | 12.08% | Citigroup | $430 → $455 | Maintains | Buy |
| 07/24/2023 | 4.69% | JMP Securities | $400 → $425 | Maintains | Outperform |
| 07/21/2023 | 13.81% | Keybanc | $372 → $462 | Maintains | Overweight |
| 06/28/2023 | 20.7% | Tigress Financial | $365 → $490 | Maintains | Buy |
| 06/26/2023 | 3.71% | Barclays | $374 → $421 | Maintains | Overweight |
| 06/26/2023 | -2.45% | Capital One | → $396 | Initiates Coverage On | → Equal-Weight |
| 06/23/2023 | 3.46% | Truist Securities | $365 → $420 | Maintains | Buy |
| 06/23/2023 | 8.39% | Morgan Stanley | $270 → $440 | Maintains | Overweight |
| 06/23/2023 | 9.62% | RBC Capital | $400 → $445 | Maintains | Outperform |
| 06/23/2023 | 1% | Wedbush | → $410 | Reiterates | Outperform → Outperform |
| 06/23/2023 | 5.92% | Needham | → $430 | Reiterates | Buy → Buy |
| 06/23/2023 | -1.47% | Piper Sandler | → $400 | Reiterates | Overweight → Overweight |
| 06/06/2023 | 1% | Canaccord Genuity | $250 → $410 | Maintains | Buy |
| 06/05/2023 | 3.46% | Goldman Sachs | $280 → $420 | Maintains | Buy |
| 06/05/2023 | 4.45% | Bernstein | $257 → $424 | Maintains | Outperform |
| 06/02/2023 | -1.47% | RBC Capital | $235 → $400 | Maintains | Outperform |
| 06/02/2023 | -7.62% | Stifel | $240 → $375 | Maintains | Buy |
| 06/02/2023 | -10.09% | Truist Securities | $235 → $365 | Maintains | Buy |
| 06/02/2023 | -45.81% | Mizuho | $180 → $220 | Maintains | Neutral |
| 06/02/2023 | 5.92% | Oppenheimer | $270 → $430 | Maintains | Outperform |
| 06/02/2023 | 5.92% | Needham | $250 → $430 | Maintains | Buy |
| 06/02/2023 | -3.93% | Baird | $290 → $390 | Maintains | Outperform |
| 06/02/2023 | 5.92% | Citigroup | $363 → $430 | Maintains | Buy |
| 06/02/2023 | -7.87% | Barclays | $280 → $374 | Maintains | Overweight |
| 06/02/2023 | -8.86% | JMP Securities | $245 → $370 | Maintains | Market Outperform |
| 06/02/2023 | 3.46% | Goldman Sachs | $280 → $420 | Maintains | Buy |
| 06/02/2023 | -1.47% | Piper Sandler | $270 → $400 | Maintains | Overweight |
| 05/31/2023 | -28.56% | Baird | $230 → $290 | Maintains | Outperform |
| 05/26/2023 | -48.27% | Guggenheim | $205 → $210 | Downgrades | Neutral → Sell |
| 05/19/2023 | -10.58% | Citigroup | $290 → $363 | Maintains | Buy |
| 05/15/2023 | -31.03% | Barclays | $257 → $280 | Maintains | Overweight |
| 04/20/2023 | -10.09% | Tigress Financial | → $365 | Reiterates | → Buy |
| 04/20/2023 | -34.97% | Keybanc | $229 → $264 | Maintains | Overweight |
| 04/12/2023 | -33.49% | Morgan Stanley | $230 → $270 | Upgrades | Equal-Weight → Overweight |
| 03/10/2023 | -38.42% | Credit Suisse | $305 → $250 | Maintains | Outperform |
| 03/09/2023 | -43.34% | Baird | → $230 | Maintains | Outperform |
| 03/09/2023 | -42.11% | RBC Capital | → $235 | Reiterates | → Outperform |
| 03/09/2023 | -31.03% | Goldman Sachs | $325 → $280 | Maintains | Buy |
| 03/09/2023 | -38.42% | Needham | $240 → $250 | Maintains | Buy |
| 03/09/2023 | -55.66% | Mizuho | $220 → $180 | Maintains | Neutral |
| 03/09/2023 | -28.56% | Citigroup | $295 → $290 | Maintains | Buy |
| 03/09/2023 | -33.49% | Oppenheimer | $320 → $270 | Maintains | Outperform |
| 03/09/2023 | -39.65% | JMP Securities | $215 → $245 | Maintains | Market Outperform |
| 03/09/2023 | -36.69% | Barclays | $264 → $257 | Maintains | Overweight |
| 03/09/2023 | -33.49% | Piper Sandler | → $270 | Reiterates | → Overweight |
| 03/07/2023 | -27.33% | Citigroup | $300 → $295 | Maintains | Buy |
| 02/22/2023 | -40.88% | Stifel | $256 → $240 | Maintains | Buy |
| 02/17/2023 | -30.53% | Bernstein | → $282 | Initiates Coverage On | → Outperform |
| 02/15/2023 | -34.97% | Barclays | $240 → $264 | Maintains | Overweight |
| 02/15/2023 | -45.81% | Mizuho | $170 → $220 | Maintains | Neutral |
| 02/06/2023 | -37.18% | Keybanc | $220 → $255 | Maintains | Overweight |
| 01/27/2023 | -49.5% | Guggenheim | → $205 | Initiates Coverage On | → Neutral |
| 01/08/2023 | -42.11% | Truist Securities | $300 → $235 | Maintains | Buy |
| 12/21/2022 | -40.88% | Needham | $225 → $240 | Maintains | Buy |
| 12/15/2022 | -10.09% | Tigress Financial | $575 → $365 | Maintains | Buy |
| 12/15/2022 | -40.88% | Wedbush | → $240 | Initiates Coverage On | → Outperform |
| 12/07/2022 | -36.94% | Stifel | $320 → $256 | Maintains | Buy |
| 12/07/2022 | -21.17% | Oppenheimer | $375 → $320 | Maintains | Outperform |
| 12/07/2022 | -43.34% | Morgan Stanley | $215 → $230 | Maintains | Equal-Weight |
| 12/07/2022 | -19.94% | Goldman Sachs | $380 → $325 | Maintains | Buy |
| 12/07/2022 | -40.88% | Barclays | $233 → $240 | Maintains | Overweight |
| 12/07/2022 | -24.87% | Credit Suisse | $400 → $305 | Maintains | Outperform |
| 12/07/2022 | -58.12% | Mizuho | $190 → $170 | Maintains | Neutral |
| 12/07/2022 | -47.04% | UBS | $200 → $215 | Maintains | Buy |
| 12/07/2022 | -47.04% | JMP Securities | → $215 | Upgrades | Market Perform → Market Outperform |
| 12/07/2022 | -44.57% | Needham | $330 → $225 | Maintains | Buy |
| 12/05/2022 | -49.5% | Baird | $330 → $205 | Maintains | Outperform |
| 11/29/2022 | -50.73% | UBS | $390 → $200 | Maintains | Buy |
| 11/28/2022 | -27.33% | Citigroup | $445 → $295 | Maintains | Buy |
| 11/21/2022 | -47.04% | Keybanc | → $215 | Initiates Coverage On | → Overweight |
| 11/21/2022 | -47.04% | Morgan Stanley | $368 → $215 | Downgrades | Overweight → Equal-Weight |
| 11/18/2022 | -42.6% | Barclays | $300 → $233 | Maintains | Overweight |
| 11/15/2022 | -53.2% | Mizuho | $300 → $190 | Maintains | Neutral |
| 10/20/2022 | -33.49% | Piper Sandler | $350 → $270 | Maintains | Overweight |
| 10/18/2022 | — | Redburn Partners | Upgrades | Sell → Neutral | |
| 10/18/2022 | -26.1% | Barclays | $360 → $300 | Maintains | Overweight |
| 09/30/2022 | -26.1% | Truist Securities | → $300 | Initiates Coverage On | → Buy |
| 09/01/2022 | -21.17% | Stifel | $340 → $320 | Maintains | Buy |
| 09/01/2022 | -11.32% | Canaccord Genuity | $300 → $360 | Maintains | Buy |
| 09/01/2022 | -18.71% | Baird | $360 → $330 | Maintains | Outperform |
| 09/01/2022 | -3.93% | UBS | $430 → $390 | Maintains | Buy |
| 09/01/2022 | -1.47% | Credit Suisse | $500 → $400 | Maintains | Outperform |
| 09/01/2022 | -18.71% | Needham | $350 → $330 | Maintains | Buy |
| 09/01/2022 | -13.78% | RBC Capital | $400 → $350 | Maintains | Outperform |
| 09/01/2022 | 9.62% | Citigroup | $450 → $445 | Maintains | Buy |
| 09/01/2022 | -11.32% | Barclays | $438 → $360 | Maintains | Overweight |
| 09/01/2022 | -13.78% | Piper Sandler | $375 → $350 | Maintains | Overweight |
| 08/22/2022 | 10.85% | Citigroup | $425 → $450 | Maintains | Buy |
| 08/17/2022 | -3.93% | Mizuho | $270 → $390 | Maintains | Buy |
| 08/16/2022 | 7.9% | Barclays | $338 → $438 | Maintains | Overweight |
| 07/18/2022 | -7.62% | Piper Sandler | $430 → $375 | Maintains | Overweight |
| 07/13/2022 | -11.32% | Baird | → $360 | Initiates Coverage On | → Outperform |
| 06/29/2022 | -53.2% | Redburn Partners | → $190 | Initiates Coverage On | → Sell |
| 06/10/2022 | -13.78% | Needham | $310 → $350 | Maintains | Buy |
| 06/09/2022 | -7.62% | RBC Capital | $325 → $375 | Maintains | Outperform |
| 06/08/2022 | -15.01% | UBS | $315 → $345 | Maintains | Buy |
| 06/02/2022 | 4.69% | Citigroup | $405 → $425 | Maintains | Buy |
| 06/02/2022 | -16.25% | Stifel | $425 → $340 | Maintains | Buy |
| 06/02/2022 | -26.1% | Canaccord Genuity | $400 → $300 | Maintains | Buy |
| 06/02/2022 | -9.35% | Morgan Stanley | $378 → $368 | Maintains | Overweight |
| 06/02/2022 | 23.17% | Credit Suisse | $650 → $500 | Maintains | Outperform |
| 06/02/2022 | -1.47% | Oppenheimer | $490 → $400 | Maintains | Outperform |
| 06/02/2022 | -16.74% | Barclays | $330 → $338 | Maintains | Overweight |
| 06/02/2022 | -23.64% | Needham | $362 → $310 | Maintains | Buy |
| 06/02/2022 | 5.92% | Piper Sandler | $585 → $430 | Maintains | Overweight |
| 06/01/2022 | -0.23% | Citigroup | $525 → $405 | Maintains | Buy |
| 05/20/2022 | -18.71% | Barclays | $410 → $330 | Maintains | Overweight |
| 05/19/2022 | -6.89% | Morgan Stanley | $475 → $378 | Maintains | Overweight |
| 05/18/2022 | -33.49% | Mizuho | $325 → $270 | Maintains | Neutral |
| 03/18/2022 | 10.85% | UBS | $345 → $450 | Upgrades | Neutral → Buy |
| 03/16/2022 | 17.01% | Morgan Stanley | $633 → $475 | Maintains | Overweight |
| 03/09/2022 | 4.69% | Stifel | $550 → $425 | Maintains | Buy |
| 03/09/2022 | -10.83% | Needham | $626 → $362 | Maintains | Buy |
| 03/09/2022 | -19.94% | Mizuho | $400 → $325 | Maintains | Neutral |
| 03/09/2022 | 1% | Barclays | $556 → $410 | Maintains | Overweight |
| 03/09/2022 | 60.12% | Credit Suisse | $700 → $650 | Maintains | Outperform |
| 03/01/2022 | 24.4% | RBC Capital | → $505 | Initiates Coverage On | → Outperform |
| 02/15/2022 | -1.47% | Mizuho | $490 → $400 | Maintains | Neutral |
| 02/11/2022 | 55.19% | Tigress Financial | → $630 | Initiates Coverage On | → Buy |
| 12/16/2021 | 55.93% | Morgan Stanley | $525 → $633 | Maintains | Overweight |
| 12/08/2021 | 34.25% | Goldman Sachs | $475 → $545 | Maintains | Buy |
| 12/07/2021 | 35.48% | Stifel | $495 → $550 | Maintains | Buy |
| 12/07/2021 | 37.95% | Canaccord Genuity | $475 → $560 | Maintains | Buy |
| 12/07/2021 | 29.33% | Morgan Stanley | $480 → $525 | Maintains | Overweight |
| 12/07/2021 | 62.58% | Citigroup | $526 → $660 | Maintains | Buy |
| 12/07/2021 | 20.7% | Mizuho | $475 → $490 | Maintains | Neutral |
| 12/07/2021 | 54.21% | Needham | $534 → $626 | Maintains | Buy |
| 12/07/2021 | 44.11% | Piper Sandler | $525 → $585 | Maintains | Overweight |
| 11/16/2021 | 72.44% | Credit Suisse | → $700 | Initiates Coverage On | → Outperform |
| 09/17/2021 | 45.34% | Barclays | $505 → $590 | Maintains | Overweight |
| 09/07/2021 | 35.48% | Argus Research | $406 → $550 | Maintains | Buy |
| 09/03/2021 | 21.94% | Stifel | $384 → $495 | Maintains | Buy |
| 09/03/2021 | 10.85% | UBS | $300 → $450 | Maintains | Neutral |
| 09/03/2021 | 18.24% | Morgan Stanley | $410 → $480 | Maintains | Overweight |
| 09/03/2021 | 15.78% | Oppenheimer | $400 → $470 | Maintains | Outperform |
| 09/03/2021 | 31.54% | Needham | $415 → $534 | Maintains | Buy |
| 09/03/2021 | 1% | Mizuho | $350 → $410 | Maintains | Neutral |
| 09/03/2021 | 24.4% | Barclays | $420 → $505 | Maintains | Overweight |
| 09/03/2021 | 29.33% | Piper Sandler | $425 → $525 | Maintains | Overweight |
| 08/24/2021 | 1% | Morgan Stanley | $377 → $410 | Maintains | Overweight |
| 08/23/2021 | 3.46% | Barclays | $390 → $420 | Maintains | Overweight |
| 07/14/2021 | -2.7% | Canaccord Genuity | $375 → $395 | Maintains | Buy |
| 07/14/2021 | -21.17% | Mizuho | $300 → $320 | Maintains | Neutral |
| 06/04/2021 | 10.85% | Citigroup | $445 → $450 | Maintains | Buy |
| 06/04/2021 | -26.1% | UBS | $325 → $300 | Maintains | Neutral |
| 06/04/2021 | -26.1% | Mizuho | $265 → $300 | Maintains | Neutral |
| 06/04/2021 | 2.23% | Needham | $409 → $415 | Maintains | Buy |
| 05/25/2021 | -7.13% | Morgan Stanley | $415 → $377 | Maintains | Overweight |
| 05/14/2021 | -23.64% | Goldman Sachs | → $310 | Initiates Coverage On | → Buy |
| 04/13/2021 | -21.17% | Mizuho | → $320 | Initiates Coverage On | → Neutral |
| 03/23/2021 | -19.94% | UBS | → $325 | Initiates Coverage On | → Neutral |
| 03/12/2021 | 0.01% | Argus Research | → $406 | Upgrades | Hold → Buy |
| 03/10/2021 | -26.1% | DA Davidson | $275 → $300 | Maintains | Neutral |
| 03/10/2021 | 2.23% | Morgan Stanley | $439 → $415 | Maintains | Overweight |
| 03/10/2021 | -7.62% | Canaccord Genuity | $430 → $375 | Maintains | Buy |
| 03/10/2021 | 0.75% | Needham | $394 → $409 | Maintains | Buy |
| 02/23/2021 | 23.17% | Citigroup | $465 → $500 | Maintains | Buy |
| 01/19/2021 | -2.94% | Needham | $341 → $394 | Maintains | Buy |
| 12/21/2020 | -5.41% | Stifel | $320 → $384 | Maintains | Buy |
| 12/17/2020 | 8.14% | Morgan Stanley | $295 → $439 | Upgrades | Equal-Weight → Overweight |
| 12/09/2020 | -22.4% | Canaccord Genuity | $290 → $315 | Maintains | Buy |
| 12/09/2020 | -16% | Needham | $290 → $341 | Maintains | Buy |
| 12/09/2020 | -19.2% | Piper Sandler | $310 → $328 | Maintains | Overweight |
| 12/07/2020 | -27.33% | Morgan Stanley | $270 → $295 | Maintains | Equal-Weight |
| 09/03/2020 | -29.3% | Barclays | $280 → $287 | Maintains | Overweight |
| 09/03/2020 | -21.17% | Stifel | $225 → $320 | Maintains | Buy |
| 09/03/2020 | -39.65% | Goldman Sachs | $215 → $245 | Maintains | Neutral |
| 09/03/2020 | -28.56% | Canaccord Genuity | $245 → $290 | Maintains | Buy |
| 09/03/2020 | -33.49% | Morgan Stanley | $205 → $270 | Maintains | Equal-Weight |
| 09/03/2020 | -32.26% | Oppenheimer | $240 → $275 | Maintains | Outperform |
| 09/03/2020 | -28.56% | Needham | $259 → $290 | Maintains | Buy |
| 09/03/2020 | -23.64% | Piper Sandler | $226 → $310 | Maintains | Overweight |
| 06/11/2020 | -49.5% | Morgan Stanley | $203 → $205 | Maintains | Equal-Weight |
| 06/05/2020 | -44.33% | Piper Sandler | $138 → $226 | Maintains | Overweight |
| 06/05/2020 | -36.2% | Needham | $253 → $259 | Maintains | Buy |
| 06/02/2020 | -37.68% | Needham | $170 → $253 | Maintains | Buy |
| 06/01/2020 | -49.99% | Morgan Stanley | $141 → $203 | Maintains | Equal-Weight |
| 05/28/2020 | -32.26% | Citigroup | $175 → $275 | Maintains | Buy |
| 05/22/2020 | -44.57% | Stifel | $160 → $225 | Maintains | Buy |
| 04/27/2020 | -58.12% | Needham | $172 → $170 | Maintains | Buy |
| 04/20/2020 | -60.59% | Stifel | $135 → $160 | Maintains | Buy |
| 03/18/2020 | -57.63% | Needham | $189 → $172 | Maintains | Buy |
| 03/18/2020 | -66.74% | Stifel | $185 → $135 | Maintains | Buy |
| 03/18/2020 | -56.89% | Citigroup | $200 → $175 | Maintains | Buy |
| 01/13/2020 | -57.88% | Morgan Stanley | $160 → $171 | Maintains | Equal-Weight |
| 01/06/2020 | — | Argus Research | Initiates Coverage On | → Hold | |
| 12/10/2019 | -59.35% | Canaccord Genuity | $185 → $165 | Maintains | Buy |
| 12/10/2019 | -60.59% | Morgan Stanley | $150 → $160 | Maintains | Equal-Weight |
| 12/10/2019 | -80.79% | Nomura | $76 → $78 | Maintains | Reduce |
| 10/29/2019 | -61.08% | Piper Sandler | → $158 | Initiates Coverage On | → Overweight |
| 10/16/2019 | -63.05% | Morgan Stanley | $160 → $150 | Maintains | Equal-Weight |
| 10/11/2019 | -61.82% | Oppenheimer | $180 → $155 | Maintains | Outperform |
| 09/05/2019 | -60.59% | Morgan Stanley | $156 → $160 | Maintains | Equal-Weight |
| 09/05/2019 | -54.43% | Stifel | $180 → $185 | Maintains | Buy |
| 09/05/2019 | -51.96% | Citigroup | $184 → $195 | Maintains | Buy |
| 09/05/2019 | -51.96% | Citigroup | $184 → $195 | Maintains | Buy |
| 09/05/2019 | -55.91% | Barclays | $178 → $179 | Maintains | Overweight |
| 08/27/2019 | -54.67% | Citigroup | $162 → $184 | Upgrades | Neutral → Buy |
| 08/13/2019 | -61.82% | Compass Point | → $155 | Initiates Coverage On | → Neutral |
| 06/19/2019 | -54.43% | Canaccord Genuity | $160 → $185 | Maintains | Buy |
| 06/19/2019 | -55.66% | Stifel | $155 → $180 | Maintains | Buy |
| 06/19/2019 | -53.69% | Keybanc | $165 → $188 | Maintains | Overweight |
| 06/06/2019 | -60.59% | Canaccord Genuity | $125 → $160 | Maintains | Buy |
| 06/06/2019 | -81.28% | Nomura | $70 → $76 | Maintains | Reduce |
| 06/06/2019 | -59.35% | Keybanc | $150 → $165 | Maintains | Overweight |
| 05/23/2019 | -62.31% | Morgan Stanley | $124 → $153 | Maintains | Equal-Weight |
| 05/15/2019 | -56.15% | Barclays | $143 → $178 | Maintains | Overweight |
| 03/14/2019 | -71.43% | Citigroup | $94 → $116 | Maintains | Neutral |
| 03/14/2019 | -69.21% | Canaccord Genuity | $95 → $125 | Maintains | Buy |
| 03/14/2019 | -63.05% | Keybanc | $100 → $150 | Maintains | Overweight |